TriMas Co. (NASDAQ:TRS – Free Report) – Equities researchers at Zacks Research lowered their FY2024 earnings per share (EPS) estimates for shares of TriMas in a report issued on Monday, November 18th. Zacks Research analyst M. Das now expects that the industrial products company will post earnings per share of $1.70 for the year, down from their previous forecast of $1.81. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q4 2024 earnings at $0.47 EPS, Q1 2025 earnings at $0.44 EPS, Q2 2025 earnings at $0.53 EPS, Q4 2025 earnings at $0.47 EPS, FY2025 earnings at $2.02 EPS, Q1 2026 earnings at $0.57 EPS, Q2 2026 earnings at $0.61 EPS and Q3 2026 earnings at $0.63 EPS.
Several other analysts have also recently weighed in on TRS. StockNews.com upgraded TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th. BWS Financial restated a “buy” rating and set a $40.00 price target on shares of TriMas in a report on Tuesday, November 5th.
TriMas Stock Performance
TriMas stock opened at $26.67 on Wednesday. TriMas has a 12-month low of $22.45 and a 12-month high of $28.51. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60. The business’s 50-day moving average price is $26.24 and its two-hundred day moving average price is $25.86. The stock has a market cap of $1.08 billion, a PE ratio of 41.36 and a beta of 0.66.
TriMas (NASDAQ:TRS – Get Free Report) last posted its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). The firm had revenue of $229.36 million for the quarter, compared to analyst estimates of $239.33 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The firm’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.57 EPS.
TriMas Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th were paid a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 0.60%. The ex-dividend date was Tuesday, November 5th. TriMas’s dividend payout ratio (DPR) is presently 25.00%.
Hedge Funds Weigh In On TriMas
Institutional investors have recently modified their holdings of the company. Innealta Capital LLC bought a new stake in TriMas during the second quarter worth $26,000. Aristides Capital LLC bought a new position in shares of TriMas during the 2nd quarter worth $245,000. Intech Investment Management LLC bought a new position in shares of TriMas during the 3rd quarter worth $269,000. Paloma Partners Management Co purchased a new stake in TriMas during the 3rd quarter worth about $293,000. Finally, XTX Topco Ltd purchased a new stake in TriMas during the 3rd quarter worth about $371,000. 99.42% of the stock is owned by institutional investors and hedge funds.
About TriMas
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
See Also
- Five stocks we like better than TriMas
- What is the S&P 500 and How It is Distinct from Other Indexes
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- 3 Healthcare Dividend Stocks to Buy
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.